TLX — Telix Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Telix Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	R2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	fx Final	fx Final	Final	Final	Final
Cash
Cash and Short Term Investments	16	79.3	84.3	440	142
Net Total Accounts Receivable
Net Total Receivables	15.1	31.3	49.3	99.7	138
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	34.5	118	159	570	330
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.59	12.8	20.9	33.6	116
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	79.7	174	277	940	1,164
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	27.6	58.3	111	205	232
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	78.2	119	175	587	749
Common Stock
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	1.57	54.5	103	353	415
Total Liabilities & Shareholders' Equity	79.7	174	277	940	1,164
Total Common Shares Outstanding